Trialsgram
beta
RCTs are beautiful
⚄
★
0
EN
⚙
View
Diabetes technology
1 trial
2019
iDCL / DCLP3
Hybrid closed-loop insulin
In
168 patients aged 14–71 with type 1 diabetes
,
hybrid closed-loop insulin delivery (Control-IQ)
improved
time-in-range and HbA1c
compared with
sensor-augmented pump therapy
.